Inhibition of pituitary prolactin secretion by human placental lactogen in rats.
Intact female rats given twice daily injections of 1 mg human placental lactogen (HPL) showed continued dioestrous vaginal smears and their ovarian corpora lutea were found to be hypertrophied and functiona. The serum prolactin level was significantly lower in these rats than in the controls at dioestrus as well as at pro-oestrus. Twice-daily injections of 0.5 or 2 mg HPL to ovariectomized rats decreased serum and pituitary levels of prolactin and increased hypothalamic activity of prolactin inhibiting hormone, although the effect was less at the lower dose. Human placental lactogen had no direct effect on pituitary prolactin secretion in vitro. These findings have demonstrated that HPL, like prolactin itself, inhibits prolactin secretion by actin
D000818:Animals; D002369:Castration; D003338:Corpus Luteum / Q000187:drug effects; D003864:Depression, Chemical; D004031:Diestrus / Q000187:drug effects; D005260:Female; D007030:Hypothalamo-Hypophyseal System / Q000502:physiology; D007031:Hypothalamus / Q000187:drug effects; D066298:In Vitro Techniques; D010902:Pituitary Gland / Q000187:drug effects* / Q000378:metabolism; D010928:Placental Lactogen / Q000494:pharmacology*; D011247:Pregnancy; D011359:Proestrus / Q000187:drug effects; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011389:Prolactin Release-Inhibiting Factors / Q000502:physiology; D051381:Rats
D011388:Prolactin; D011389:Prolactin Release-Inhibiting Factors; D010928:Placental Lactogen